Terms: = Skin cancer AND RAD51B, ENSG00000182185, 5890, RAD51L1, O15315, hREC2, R51H2, REC2, MGC34245
4 results:
1. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Rozeman EA; Menzies AM; van Akkooi ACJ; Adhikari C; Bierman C; van de Wiel BA; Scolyer RA; Krijgsman O; Sikorska K; Eriksson H; Broeks A; van Thienen JV; Guminski AD; Acosta AT; Ter Meulen S; Koenen AM; Bosch LJW; Shannon K; Pronk LM; Gonzalez M; Ch'ng S; Grijpink-Ongering LG; Stretch J; Heijmink S; van Tinteren H; Haanen JBAG; Nieweg OE; Klop WMC; Zuur CL; Saw RPM; van Houdt WJ; Peeper DS; Spillane AJ; Hansson J; Schumacher TN; Long GV; Blank CU
Lancet Oncol; 2019 Jul; 20(7):948-960. PubMed ID: 31160251
[TBL] [Abstract] [Full Text] [Related]
2. Germline rad51b truncating mutation in a family with cutaneous melanoma.
Wadt KA; Aoude LG; Golmard L; Hansen TV; Sastre-Garau X; Hayward NK; Gerdes AM
Fam Cancer; 2015 Jun; 14(2):337-40. PubMed ID: 25600502
[TBL] [Abstract] [Full Text] [Related]
3. [What's new in dermatological research?].
Misery L
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 5():S188-93. PubMed ID: 23522705
[TBL] [Abstract] [Full Text] [Related]
4. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy.
Dessureault S; Soong SJ; Ross MI; Thompson JF; Kirkwood JM; Gershenwald JE; Coit DG; McMasters KM; Balch CM; Reintgen D;
Ann Surg Oncol; 2001 Dec; 8(10):766-70. PubMed ID: 11776489
[TBL] [Abstract] [Full Text] [Related]
